<DOC>
	<DOC>NCT00522782</DOC>
	<brief_summary>To study the improvement in airway inflammation in children with asthma non-invasively with exhaled breath NO, a marker of inflammation, after therapy with nebulized budesonide as 0.5mg daily.</brief_summary>
	<brief_title>Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children</brief_title>
	<detailed_description>Comparisons will be made before and after 2 week therapy of nebulized budesonide in children not on prior anti-inflammatory medications.</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Asthma diagnosis previously for 6 months Past asthma medication without change for previous 6 months Increased NO levels and ability to perform maneuver ICF signed by parents Systemic steroids in past 60 days,inhaled/nebulized steroids in past 4 weeks Hospitalization within 3 months Upper or lower airways active infection or cigarette smoke direct exposure Use of other asthma medications other than bronchodilators one month prior and during the trial Noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>